Enamel matrix derivative promotes new bone formation in xenograft assisted maxillary anterior ridge preservation - a randomized controlled clinical trial

Loading...
Thumbnail Image
File version

Accepted Manuscript (AM)

Author(s)
Mercado, Faustino
Vaquette, Cedryck
Hamlet, Stephen
Ivanovski, Saso
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2021
Size
File type(s)
Location
License
Abstract

OBJECTIVES: To compare the effectiveness of deproteinized bovine bone mineral with 10% collagen alone (DBBMC) or with enamel matrix derivative (DBBMC-EMD) in ridge preservation. METHODS: 42 maxillary anterior teeth were extracted and received either a DBBMC (control) or DBBMC-EMD (test) treatment protocol. CBCT taken before and 4 months after the extraction procedure was used to measure changes in alveolar ridge width (RW), buccal bone height (BH) and palatal bone height (PH). Bone cores were harvested during implant osteotomy preparation and the samples processed histomorphometrically to assess the fraction of new bone (%NB), residual graft (%RG), and soft tissue matrix (%STM). RESULTS: Overall, both treatment groups showed significant reductions in mean RW from baseline to 4 months after extraction, but no significant change in either mean BH or PH over this time. When CBCT measurements were analysed according to the initial thickness of the buccal wall (BT <1 mm vs. BT ≥1 mm), significant reductions in all ridge dimensions (RW, BH and PH) were noted in the <1 mm BT group. Histomorphometrically, the DBBMC-EMD test group showed significantly increased new bone formation (%NB): (control = 16.5 ± 6.9% cf.; test = 45.1 ± 8.8%) with less residual graft (%RG): (control = 36.8 ± 8.8% cf.; test = 20.3 ± 7.2%) compared to the DBBMC control group. CONCLUSIONS: DBBMC alone and DBBMC-EMD treated sites 4 months after extraction both lost RW but showed no significant change in BH or PH. Irrespective of treatment, maxillary anterior teeth with thick initial buccal walls (≥1 mm) exhibited less alveolar ridge reduction 4 months after treatment. The addition of EMD to DBBMC stimulated bone formation in the test group.

Journal Title

Clinical Oral Implants Research

Conference Title
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2021 John Wiley & Sons A/S. This is the peer reviewed version of the following article: Enamel matrix derivative promotes new bone formation in xenograft assisted maxillary anterior ridge preservation - a randomized controlled clinical trial, Clinical Oral Implants Research, 2021, which has been published in final form at https://doi.org/10.1111/clr.13742. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-828039.html)

Item Access Status
Note
Access the data
Related item(s)
Subject

Biomedical engineering

Dentistry

Clinical sciences

CBCT

deproteinized bovine bone mineral with 10% collagen

enamel matrix derivative

histomorphometry

ridge preservation

Persistent link to this record
Citation

Mercado, F; Vaquette, C; Hamlet, S; Ivanovski, S, Enamel matrix derivative promotes new bone formation in xenograft assisted maxillary anterior ridge preservation - a randomized controlled clinical trial, Clinical Oral Implants Research, 2021

Collections